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ABSTRACT 
Objectives 
 To compare the effectiveness of risk of malignancy index 1 and 2 to 
differentiate between benign and malignant ovarian tumors. 
 Methodology 
        CA 125 level was done by ECLIA <Enzyme chemi luminescent  
Immunoassay>. In my study based on ultrasound features, menopausal status, and CA 
125 levels RMI 1 & RMI 2 scoring is calculated in women above age 40 years with 
ovarian tumors. Ultrasound findings were scored with one point for each of the 
following : mutilocular cyst , evidence of solid areas , evidence of metastasis, 
presence of ascites, bilateral lesions (zero points for women with no abnormality, one 
point for women with one abnormality, in women with two or more abnormality 3 
points given in RMI 1 , 4 points given in RMI 2). Menopausal status is graded as 
follows : premenopausal status is graded M = 1 , postmenopausal status is graded as 
M=3 in RMI 1 , M=4 in RMI 2 .  
RESULTS: 
In my study RMI 2 has the advantage over RMI 1 to differentiate benign and 
malignant ovarian tumors. Cut off value to differentiate benign and malignant tumors 
was 200. Sensitivity and negative predictive value is 100% for both RMI 1 & RMI 2. 
Specificity of RMI 2 is 52.5%, for RMI 1 is 47.5%.Positive predictive value of RMI 1 
is 32.26%, RMI 2 is 34.48%. Accuracy of RMI 1 IS 58%,for RMI 2 is 62%. 
CONCLUSION: 
RMI 2 is simple scoring system which is more reliable to identify malignant 
ovarian tumors. Preoperative evaluation by using this scoring system helps to avoid 
unnecessary surgical intervention.  
        
 
 
 
